Introduction
============

In the last 20 years, direct-fed-microbials (DFM) supplementation to improve the health and performance of livestock has generated a great interest. Specifically for feedlot beef cattle, main targets for probiotics are health promotion to avoid or reduce ruminal acidosis, increase weight gain and feed conversion as well as human pathogens shedding decrease ([@B54]). Ruminants benefit from the symbiosis between the host and the rumen microbes, which supply protein, vitamins and short chain organic acids for the animal host ([@B12]). Defined as "live microorganisms which when administered in adequate amounts confer a health benefit on the host" ([@B21]; [@B29]), probiotic bacteria represent a new and efficient alternative to traditional prophylactic therapies for animal management in artificial environments. The increased interest for DFM application constitute a driving force to reduce or eliminate the use of low-dose antibiotics in livestock production; low antibiotic concentrations found in natural environments lead to enrich resistant bacterial populations ([@B28]). In the European Union, the use of antibiotics for animal growth promotion was banned in 2006 and a similar ban for animal husbandry is currently discussed in United States of America ([@B9]). Internationally, many countries have adopted mandatory restrictions on antimicrobial use, and veterinary prescription to use these drugs in food animals are obligatory ([@B44]).

According to WHO (World Health Organization) to attain a probiotic status, microorganisms have to meet some of the principles related to their safety and biological properties. Lactic acid bacteria (LAB), besides their essential role in food fermentations are also important as probiotics. For this type of use, requirements for safety assessment have increased; they should not exhibit neither pathogenic activity nor antibiotic resistance (AR) encoding genes and sustain genetic stability. The evaluation of the antibiotic susceptibility of LAB has recently grown because of their potential to spread resistance by horizontal gene transfer in which plasmids, transposons and integrons are involved; these mobile elements include AR genes mostly responsible for intra- and inter-species transfer of genetic material ([@B60]; [@B26]). The large numbers of LAB in fermented products and in the gastrointestinal tract (GIT) supports the presence of different resistance mechanisms via mutation; once a bacteria becomes resistant, the element is amplified and may be transmitted to another host. *Enterococcus* species have been described as a major source of nosocomial infections in human and veterinary medicine and a correlation of AR and infective determinants was established ([@B24]). Enterococci factors that contribute to pathogenesis include cytolysin, aggregation substance, adhesins and hydrolytic enzymes ([@B23]). Remarkably, food isolated enterococci were shown to harbor either single or multiple virulence factors, however, their incidences among probiotic enterococci strains were noticeably lower ([@B23]; [@B8]; [@B33]). Although lower occurrence, AR for non-enterococcal LAB emerged from medical, veterinary and food sources; the presence of potentially transferable resistance genes has been established, which appear to be intrinsic as well as transferable ([@B5]; [@B17]; [@B3]). Among the microorganisms used in animal feed, mainly Gram-positive bacterial strains that act as bioregulators of the intestinal microbiota and enhancers of host's natural defenses, were applied ([@B29]). As normal components of animal GIT microbiota, different genera and species of LAB were used to potentially modulate GI microbial health, nutrient use and animal productivity ([@B54]).

On the other hand, as first step for probiotic delivery to feedlot cattle, optimization of an effective and low cost growth medium for culturing LAB must be achieved. Because LAB are fastidious microorganisms and many elements like carbohydrates, amino acids, peptides, vitamins and Mg/Mn salts are required for growth, commercial media are generally optimal, but due to the high cost they result inappropriate for large-scale biomass production. In addition, LAB growth activity is affected by culture conditions such as pH, temperature, medium formulation, and others. Among ingredients, yeast extract was found as highly significant for enhanced biomass production in low cost cultivation conditions ([@B13]; [@B43]). In this study, in view to design a probiotic formula for its administration to feedlot cattle, AR and virulence factors incidence for 40 LAB strains isolated from cattle environment, were investigated. In addition, optimal growth conditions of selected probiotic LAB strains were preliminary investigated for high cell mass production.

Materials and Methods {#s1}
=====================

Microorganisms and Growth Conditions
------------------------------------

Forty LAB previously isolated from feedlot cattle environment and selected for their beneficial characteristics ([@B41]) were used, including *Lactobacillus (L.) acidophilus* (3), *L. amylovorus* (4), *L. casei* (1), *L. fermentum* (1), *L. mucosae* (14), *L. plantarum* (3), *L. rhamnosus* (1), *Pediococcus (P.) acidilactici* (2), *Enterococcus (E.) durans* (3), *E. faecium* (2) and *E. hirae* (6). Inoculum of strains were prepared by transferring glycerol stock culture to MRS broth (Merck, Darmstadt, Germany) and sub-cultured twice in the same media at 37°C for 16 h.

Safety Evaluation
-----------------

### Phenotypic Antibiotic Resistance and MIC Determination

Minimum inhibitory concentrations (MIC, μg/ml) of eight antibiotics: ampicillin (AMP), clindamycin (CLI), chloramphenicol (CHL), erythromycin (ERY), gentamicin (GEN), kanamycin (KAN), tetracycline (TET), and streptomycin (STR) were determined for LAB strains (40) according to ISO 10932:2010 standard. Epidemiological cut-off values based on the recommendation of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and [@B19] Panel on Additives and Products or Substance used in Animal Feeding (FEEDAP) were applied. All antibiotics were purchased from Sigma--Aldrich (St. Louis, MO, United States and ICN Biomedicals, Santa Ana, CA, United States). In parallel, accuracy of susceptibility testing was monitored by the use of quality control strains (*Lactobacillus plantarum* ATCC14917, *Enterococcus faecalis* ATCC29212).

### Hemolysin and Gelatinase Activity

Hemolysin activity was determined on Columbia Blood Agar (Oxoid) containing 5% defibrinized horse blood after 48 h of incubation at 37°C, both under aerobic and anaerobic conditions. Zones of clearing around colonies indicated β-haemolysin production. Gelatinase production was detected by inoculating LAB onto freshly prepared peptone-yeast extract agar containing gelatin (30 g/L; Difco). Plates were incubated overnight at 37°C and cooled at ambient temperature for 2 h. The appearance of a turbid zone around the colonies was considered as positive result for gelatinase production.

### PCR Detection of Antimicrobial Resistance Genes and Potential Virulence Factors

The presence of genes coding for AR in LAB strains phenotypically susceptible to antibiotics (described above) and virulence factors were evaluated through PCR reactions. Specific primers used and their target genes, amplicon sizes and PCR protocol references used for genes detection are shown in **Table [1](#T1){ref-type="table"}**. PCR-amplifications were performed from total bacteria DNA obtained according to [@B52] in 25 μl reaction mixture containing 1 μl of purified DNA, 1 μM of each primers, 0.1 mM of each dNTP (2.5 Mm), buffer 1x, 1.5 mM MgCl~2~ (25 Mm) and 2.5 U/100 μl of Taq polymerase (Inbio Highway, Argentina). Samples were subjected to an initial cycle of denaturation (94°C for 5 min), followed by 28 cycles of denaturation (94°C for 1 min), annealing for 1 min at the temperature of the primer pairs and elongation (72°C for 1 min 30 seg), ending with one cycle of final extension (72°C for 5 min) in a MyCyclerTM (BioRad, Richmond, CA, United States) thermocycler. PCR-products were separated by electrophoresis on 1% (w/v) agarose at 80 V for 45 min. Gels were stained with GelRedTM (Biotium Inc., Hayward, CA, United States) and visualized with a UV light transilluminator (320 nm). The molecular size marker used was 1 kb Plus DNA ladder (Invitrogen, Buenos Aires, Argentina).

###### 

Genes targeting to antibiotic resistance and virulence determinants used in this study.

  Primer pair          Target Gene (Antibiotics)                       Primer sequence (5′-3′)        Amplicon size (bp)   T°C   References
  -------------------- ----------------------------------------------- ------------------------------ -------------------- ----- ----------------------
  Bla-F                *bla* (Ampicillin)                              CATARTTCCGATAATASMGCC          297                  48    [@B31]
  Bla-R                                                                CGTSTTTAACTAAGTATSGY                                      
  Cat-F                *cat* (Chloramphenicol)                         TTAGGTTATTGGGATAAGTTA          300                  50    [@B31]
  Cat-R                                                                GCATGRTAACCATCACAWAC                                      
  erm(B)-F             *erm*(B) (Erythromycin)                         CATTTAACGACGAAACTGGC           640                  60    [@B49]
  erm(B)-R                                                             GGAACATCTGTGGTATGGCG                                      
  erm(C)-F             *erm*(C) (Erythromycin)                         CAAACCCGTATTCCACGATT           295                  60    [@B49]
  erm(C)-F                                                             ATCTTTGAAATCGGCTCAGG                                      
  aac(6′)-aph(2′′)-F   *aac*(6′)*aph*(2′′)                             CCAAGAGCAATAAGGGCATA           220                  52    [@B49]
  aac(6′)-aph(2′′)-R   (Gentamicin)                                    CACTATCATAACCACTACCG                                      
  aph(3′′)-III-F       *aph*(3′′)-III                                  GCCGATGTGGATTGCGAAAA           292                  60    [@B49]
  aph(3′′)-III-R       (Kanamycin)                                     GCTTGATCCCCAGTAAGTCA                                      
  StrA-F               *str*A (Streptomycin)                           CTTGGTGATAACGGCAATTC           548                  60    [@B49]
  StrA-R                                                               CCAATCGCAGATAGAAGGC                                       
  StrB-F               *str*B (Streptomycin)                           ATCGTCAAGGGATTGAAACC           509                  57    [@B49]
  StrB-R                                                               GGATCGTAGAACATATTGGC                                      
  AadA-F               *aad*A (Streptomycin)                           ATCCTTCGGCGCGATTTTG            282                  65    [@B49]
  AadA-R                                                               GCAGCGCAATGACATTCTTG                                      
  AadE-F               *aad*E (Streptomycin)                           ATGGAATTATTCCCACCTGA           565                  57    [@B49]
  AadE-R                                                               TCAAAACCCCTATTAAAGCC                                      
  ant(6)-F             *ant*(6) (Streptomycin)                         ACTGGCTTAATCAATTTGGG           597                  60    [@B14]
  ant(6)-R                                                             GCCTTTCCGCCACCTCACCG                                      
  tet(M)-F             *tet*(M) (Tetracycline)                         GTGGACAAAGGTACAACGAG           406                  57    [@B47]
  tet(M)-R                                                             CGGTAAAGTTCGTCACACAC                                      
  tet(K)-F             *tet*(K) (Tetracycline)                         TTAGGTGAAGGGTTAGGTCC           697                  57    [@B1]
  tet(K)-R                                                             GCAAACTCATTCCAGAAGCA                                      
  tet(L)-F             *tet*(L) (Tetracycline)                         CATTTGGTCTTATTGGATCG           456                  57    [@B1]
  tet(L)-R                                                             ATTACACTTCCGATTTCGG                                       
  tet(S)-F             *tet*(S) (Tetracycline)                         TGGAACGCCAGAGAGGTATT           660                  57    [@B49]
  tet(S)-R                                                             ACATAGACAAGCCGTTGACC                                      
  **Primer pair**      **Target Gene (Virulence factors)**             **Primer sequence (5′-30′)**   **Amplicon**               **References**
                                                                                                      size (bp)                  
  Agg-F                *agg*                                           AAGAAAAAGAAGTAGACCAAC          1553                 53    [@B20]
  Ace-R                (Aggregation protein)                           AAACGGCAAGACAAGTAAATA                                     
  Ace-F                *Ace*                                           CAGGCCAACATCAAGCAACA           125                  65    [@B4]
  Ace-R                (Accessory colonization factor)                 GCTTGCCTCGCCTTCTACAA                                      
  EspA-F               *esp*A (Enterococcal surface protein)           TTTGGGGCAACTGGAATAGT           407                  60    [@B4]
  EspA-R                                                               CCCAGCAAATAGTCCATCAT                                      
  Ebp-F                *ebp*                                           AATGTGTTAAACCATCAAGGGAAT       372                  62    [@B56]
  Ebp-R                (Endocarditis and Biofilm-associated Pilus)     ACTCCTTTTTGAACTTCACCAATC                                  
  CylA-F               *cyl*A (Cytolisin)                              ACTCGGGGATTGATAGGC             688                  60    [@B61]
  CylA-R                                                               GCTGCTAAAGCTGCGCTT                                        
  HyI-F                *hyI* (Hyaluronidase)                           ACAGAAGAGCTGCAGGAAATG          276                  62    [@B61]
  HyI-R                                                                GACTGACGTCCAAGTTTCCAA                                     
  GelE-F               *gel*E (Gelatinase)                             CGAAGTTGGAAAAGGAGGC            372                  50    [@B4]
  GelE-R                                                               GGTGAAGAAGTTACTCTGA                                       
  SprE-F               *spr*E (Serineprotease)                         GGTAAACCAACCAAGTGAATC          300                  57    [@B4]
  SprE-R                                                               TTCTTCCGATTGACGCAAAA                                      
  fsr A-F              *fsr*A                                          TGATGATGATTGATTGATGGAC         744                  60    [@B53]
  fsr A-R              (Quorum sensing genes)                          ATTACAAGTGGCACACCAGGAC                                    
  fsr B-F              *fsr*B                                          TGGACAAAGTATTATCTAACCG         729                  57    [@B53]
  fsr B-R              (Quorum sensing genes)                          CACACCATCACTGACTTTTGC                                     
  fsr C-F              *fsr*C                                          ATCGTGTGTTAGAAAATAGC           1344                 52    [@B53]
  fsr C-R              (Quorum sensing genes)                          ACGAATCACAACCACTAAGTC                                     
  AtpA-F               *atp*A                                          CCAGGTCGTGAAGCTTATCC           110                  63    [@B55]
  AtpA-R               (F0F1-ATP synthase subunit alpha)               GGTAAGGCCGTCATTGAACC                                      
  cfa1-F               *cfa1*                                          ACGACCTGTTGTTCGACCTG           150                  63    [@B55]
  cfa1-R               (Cyclopropane-fatty acylphospholipidsynthase)   AGGGGGCTATATCCCAAATG                                      
  mleS-F               *mle*S                                          ACAAGGTCTCAGCGTTCAGC           140                  64    [@B55]
  mleS-R               (Malatedehydrogenase)                           GACTGGGATTCCAGCTGATG                                      
  HisD-F               *his*D                                          TGAACCACTCGGTGACTACG           150                  62    [@B55]
  HisD-R               (Histidinoldehydrogenase)                       GGAGCTTCCTTAGCCAAAGC                                      
  groEL-F              *gro*EL                                         GTTTGATCGCGGCTATCTGA           150                  55    Koirala et al., 2015
  groEL-R              (Stress response)                               CCTTGTTGMACGATTTCTTG                                      

Optimization of Growth Medium for Probiotic Strains Production
--------------------------------------------------------------

Based on safety results, *L. acidophilus* CRL2074, *L. amylovorus* CRL2116, *L. mucosae* CRL2069, and *L. rhamnosus* CRL2084 were selected and the impact of different culture media formulated with various ingredients on biomass production was investigated. Five combinations of different components, MRS and MRSc (pH was controlled by adding NaOH 5N at 6, 18, and 24 h) were evaluated, their compositions being shown in **Table [2](#T2){ref-type="table"}**. Before the trial, selected LAB strains were inoculated (2%) in 5 ml of each prepared media and sub-cultured twice during 12 h at 37°C. For each medium and LAB strain, viable LAB were quantified after dilutions and plating on MRS agar. Maximum growth rate (μ h^-1^) and growth potential (CFU/mL at 24 h -- CFU/mL at 0 h) were determined.

###### 

Culture media used and their composition.

                            Media composition (g L^-1^)                               
  ------------------------- ----------------------------- ------ ------- ------ ----- ------
  Peptone casein            9                             --     --      --     --    --
  Beef peptone              --                            --     --      --     --    10
  Skim milk powder          --                            --     10      --     100   --
  Yeast extract             3.12                          20     10      3.12   10    5
  WPC 80                    --                            --     --      9      --    --
  Beef extract              --                            --     --      --     --    10
  Glucose                   6.27                          10     --      6.27   --    20
  Lactose                   --                            --     30      --     --    --
  Ammonium citrate          --                            2      --      --     --    2
  Sodium acetate            --                            5      --      --     --    5
  [L]{.smallcaps}-cistein   0.25                          --     --      0.25   --    --
  KH~2~PO~4~                --                            --     5.6     --     --    2
  Na~2~HPO~4~               6.27                          --     3.6     6.27   --    --
  NaCl                      2.5                           --     --      2.5    --    --
  MgSO~4~cdot7H~2~O         --                            0.1    0.05    --     --    0.1
  MnSO~4~cdotH~2~O          --                            0.05   0.038   --     --    0.05
  Tween 80                  --                            1^∗^   --      --     --    1^∗^
  pH                        6.5                           5.9    6.5     6.5    6.2   6.5

∗

Tween 80: ml/l;

§

WPC 80: soluble protein concentrate from whey

.

Compatibility of Selected LAB Strains
-------------------------------------

Beneficial LAB strains previously selected were tested for interactions among them. MRS (15 ml) melted and tempered at 45°C were vigorously mixed with 200 μL of an overnight culture of each LAB and poured into Petri dishes. Wells of 10 mm in diameter were cut in the agar and 30 μL of the cell-free supernatant of each strain was placed into each well. The plates were incubated aerobically overnight at 37°C, and inhibition halos observed.

Statistics
----------

Agar assays were performed by duplicate and growth curves by triplicate. In the case of AR, media values were compared with cut-off points. The media and SD were calculated for growth curves, results (means OD ± SD) being evaluated by the application of ANOVA to define differences and statistical significances were determined by the Tukey test.

Results and Discussion
======================

Antimicrobial Susceptibility Testing
------------------------------------

The use of probiotics instead of antibiotic therapy is gaining acceptance worldwide to alleviate antibiotic-mediated complications and enhance livestock health conditions. However, safety concerns have been raised by the use of LAB strains carrying AR genes themselves, as they can potentially transfer them to other commensal and/or pathogenic bacteria through horizontal gene mechanisms ([@B33]). Thus, to use as probiotics, safety traits of forty LAB strains previously isolated and identified from feedlot cattle environment ([@B41]), were investigated. The MIC of eight antimicrobial agents for 40 LAB strains involving *Lactobacillus* (27), *Pediococcus* (2), *Enterococcus* (11) strains, was determined. Results showed that the obtained MICs were in the range (μg/ml) of 0.063-16 (CLI); 0.125-64 (CHL); 0.25-16 (ERY); 0.5-64 (GEN); 1-128 (STR) and 0.5-128 (TET); ≤ 0.032 (AMP) and ≤ 1024 (KAN), as shown in **Table [3](#T3){ref-type="table"}**. Feedlot lactobacilli were found resistant to the glycopeptide VAN (data not shown), this phenotype being characterized as an intrinsic resistance in LAB ([@B26]). Similarly, all strains were sensitive toward the β-lactam AMP in coincidence with that reported for probiotics *L. acidophilus*, *L. rhamnosus*, and *L. casei*, commercial starter *L. plantarum* and *L. mucosae* strains ([@B31]; [@B37]); however resistance toward AMP was described for chicken lactobacilli ([@B16]). Although resistance to aminoglycosides has been often observed for probiotic and starter lactobacilli ([@B31]; [@B46]; [@B3]), GEN, KAN, and STR sensitivity was repeatedly described in feedlot lactobacilli (\>92%) (**Table [3](#T3){ref-type="table"}**). Only *Lactobacillus* CRL2158 was resistant to GEN, *L. plantarum* CRL2103 exhibited resistance to KAN and *L. acidophilus* CRL2074, *L. amylovorus* CRL2065 as well as *L. mucosae* CRL2155 were resistant to STR. In coincidence, low lactobacilli resistance to aminoglycosides was reported for chicken intestinal LAB strains ([@B16]). In this study, the low MICs found for feedlot *L. mucosae* strains agrees with that described for wild boars fecal strains ([@B37]). In addition, resistance to STR of *L. acidophilus* from human origin and *L. amylovorus* from broilers were reported ([@B10]; [@B36]). On the other hand, high prevalence of KAN resistance was described for *L. acidophilus*, *L. rhamnosus*, and *L. casei* from probiotic products ([@B59]). Resistance/sensitivity of *L. plantarum* to KAN were found to be controversial, strains isolated from probiotic products and fermented foods were reported as susceptible ([@B59]), while resistance was described by [@B46]. Discrepancies might be assigned to differences in the evaluated species, applied methods or strains source.

###### 

Distribution of MICs and antibiotic resistance genes among **lactobacilli** and **pediococci** isolated from feedlot environment.

  LAB                 Strain (CRL)   Origin                     CLI      CHL      ERY      GEN      KAN       STR       TET       Resistance gene(s)
  ------------------- -------------- -------- ----------------- -------- -------- -------- -------- --------- --------- --------- --------------------------
  *L. acidophilus*                            *Cut-off value*   *1*      *4*      *1*      *16*     *64*      *16*      *4*       
                      2061           CF       MIC               0.063    4        0.5      2        32        2         **64**    
                      2074           CF                         **2**    4        0.25     0.5      8         **64**    **32**    
                      2152           CF                         0.125    4        0.5      2        8         2         **128**   *erm*B
  *L. amylovorus*                             *Cut-off value*   *1*               *1*      *16*     *16*      *16*      *4*       
                      2044           CF       MIC               **16**   1        0.25     2        8         1         **16**    
                      2065           CF                         0.4      2        **8**    2        8         **128**   **16**    
                      2115           PS                         0.4      4        1        2        4         1         **128**   
                      2116           PS                         0.4      4        0.25     2        16        1         **64**    
  *L. casei*                                  *Cut-off value*   *1*      *4*      *1*      *16*     *64*      *64*      *4*       
                      2088           PS       MIC               0.125    4        **4**    16       32        64        0.5       *aph*(3′′)-III, *aadA*
  *L. fermentum*                              *Cut-off value*   *1*      *4*      *1*      *16*     *64*      *64*      *8*       
                      2085           FR       MIC               0.032    4        0.016    0.5      16        4         4         *erm*B, a*nt*(6), *aadA*
  *L. mucosae*                                *Cut-off value*   *1*      *4*      *1*      *16*     *64*      *32*      *8*       
                      2063           PS       MIC               0.125    **64**   **16**   16       64        32        **64**    
                      2064           CF                         0.032    2        1        4        32        2         **64**    
                      2069           CF                         0.032    2        1        4        4         2         **32**    
                      2070           PS                         0.125    4        0.5      2        16        2         **64**    
                      2083           CF                         0.063    2        0.25     2        8         2         **64**    
                      2100           PS                         0.063    2        **4**    0.5      16        2         **16**    
                      2101           PS                         0.063    4        **4**    0.5      8         2         **128**   *erm*B
                      2111           CF                         0.063    2        0.25     0.5      2         2         **64**    
                      2112           CF                         0.063    4        0.5      0.5      0         8         **128**   
                      2113           CF                         **16**   **64**   **16**   0.5      32        2         **16**    *erm*B
                      2114           CF                         0.063    2        1        0.5      8         2         **128**   *erm*B
                      2154           CF                         0.063    4        1        0.5      0         2         **128**   *erm*B
                      2155           CF                         0.125    2        **32**   16       16        **64**    1         *tet*S
                      2158           CF                         0.063    0.125    **32**   **32**   8         32        **128**   
  *L. plantarum*                              *Cut-off value*   *2*      *8*      *1*      *16*     *64*      *n.r*     *32*      
                      2103           FR       MIC               **4**    8        **4**    2        **512**   16        32        *bla*
                      2126           FR                         2        8        **2**    1        32        8         32        *cat*
                      2142           FR                         0.125    8        **4**    1        32        16        **64**    *bla*, *tet*S
  *L. rhamnosus*                              *Cut-off value*   *1*      *4*      *1*      *16*     *64*      *32*      *8*       
                      2084           FR       MIC               0.25     4        **2**    4        32        8         8         
  *P. acidilactici*                           *Cut-off value*   *1*      *4*      *1*      *16*     *64*      *64*      *4*       
                      2043           CF       MIC               0.032    2        **8**    16       64        16        **16**    
                      2046           FR                         0.032    2        **8**    16       64        16        **16**    

Cut-off values proposed by the

EFSA-FEEDAP (2012)

and MIC are expressed in μg mL

\-

1

;

n.r

, not required; number in bold indicate antibiotic resistance. CF, cattle feces; PS, pens soil; FR, feed rations

.

Generally, lactobacilli were sensitive to antibiotics inhibiting protein synthesis, such as CLI, CHL, ERY, and TET ([@B5]; [@B36]). In agreement, high susceptibility (MICs below the cut-off value) to CLI and CHL was described among feedlot lactobacilli involving 85.2 and 92.6% of strains, respectively. Similar results were reported for lactobacilli isolated from chickens and wild boar feces ([@B37]; [@B16]), however, high prevalence of lincosamides (CLI) resistance was published for broilers cloacal lactobacilli ([@B10]). With the exception of *L. acidophilus* and *L. fermentum*, all other lactobacilli (44.5%) showed to be resistant to ERY. These results are in line with those reported for human and animal *L. rhamnosus, L. amylovorus*, probiotic *L. casei* and meat starter *L. plantarum* strains ([@B10]; [@B31]; [@B26]) while feedlot *L. mucosae* resistance (43%) toward ERY resulted higher to that reported for wild boars intestinal strains ([@B37]). Moreover, an unexpected high prevalence of TET resistance was observed among feedlot *Lactobacillus* (78% of the strains) with MICs values far beyond the cut-off value (128 μg/ml). *L. acidophilus* CRL2152, *L. amylovorus* CRL2115 and 4 strains of *L. mucosae* exhibited the highest TET resistance level in agreement with those reported for food and animal feces lactobacilli ([@B37]; [@B57]).

When feedlot pediococci were analyzed, resistance toward ERY and TET, while sensitivity to the other antimicrobials were obtained (**Table [3](#T3){ref-type="table"}**). Susceptibility to AMP, CHL, GEN, and STR is in accordance to previous results ([@B15]; [@B31]). *P. acidilactici* (two strains) resistances to ERY and TET agree to that described for food and animal strains ([@B5]; [@B15]; [@B31]) starter strains ([@B31]), respectively. Nonetheless, as reported by [@B15], pediococci are intrinsically resistant to TET in addition to VAN. On the other hand, enterococci as commensal inhabitants of the GIT of warm-blooded animals were dominant in feedlot environment ([@B41]). Since this genus emerged as important human and veterinary pathogen/opportunist, the incidence of antimicrobial resistance and virulence determinants were also investigated. Feedlot enterococci, mostly isolated form cattle feces, showed sensitivity to AMP, CHL, KAN and STR while resistance to CLI, ERY, GEN and TET (73, 100, 54.5, and 73%, respectively) was displayed (**Table [4](#T4){ref-type="table"}**). Susceptibility of enterococci to AMP and CHL is in accordance to that previously reported ([@B6]), and similar sensitivity to STR for enterococci isolated from feedlot steers was described by [@B8]. In agreement, low incidence (\<10%) of KAN and CHL resistance was reported for wild game Spanish meat enterococci ([@B27]). Resistance to GEN found in 56% of *Enterococcus* agrees with that reported by [@B34] for pet animal's enterococci. The unexpected high percentage of feedlot enterococci resistant to CLI (82%), ERY (100%) and TET (73%) are concordant with that reported for dairy/bison cattle and pet feces ([@B6]; [@B35]; [@B34]; [@B8]). Among the recovered enterococci from feedlot steers feces, *E. hirae* was revealed to predominate ([@B41]) and was also described among the highest antibiotic resistant enterococci species ([@B8]). In addition, multi-resistance to at least three antimicrobial agents were found for 30% of feedlot strains in which CLI was mostly involved for enterococci strains (**Table [4](#T4){ref-type="table"}**). Fifteen lactobacilli isolates (37.5%) were resistant to only one antibiotic, *L. casei*, *L. plantarum*, and *L. rhamnosus* strains showing ERY with MICs 1 ≥ μg/ml, while *L. acidophilus*, *L. amylovorus*, and *L. mucosae* exhibited TET MICs ≥ 4 μg/ml. Similarly, [@B37] reported multi-resistance to CHL/KAN/STR/TET for *L. mucosae* strains isolated from wild boars feces. Specifically for enterococci, multidrug resistance patterns found are in agreement to that reported for *E. hirae*, *E. faecium*, and *E. durans* from dairy cows feces, *E. hirae* being resistant up to seven antimicrobials ([@B35]). Nevertheless, *L. fermentum* CRL2085 from feedlot cattle was phenotypically sensitive to all assayed antibiotics in this study, in disagreement to that reported for fermented food and animal/human feces strains which were resistant to ERY and TET ([@B5]; [@B46]; [@B57]).

###### 

Distribution of MICs and virulence genes among **enterococci** isolated from feedlot.

  LAB            Strain (CRL   Origin   CLI        CHL    ERY      GEN      KAN      STR     TET       Virulence genes
  -------------- ------------- -------- ---------- ------ -------- -------- -------- ------- --------- -----------------
                                        *1^∗^*     *16*   *4*      *32*     *1024*   *128*   *4*       
  *E. durans*    2047          CF       **8**^§^   8      **16**   **64**   1024     32      0.5       *ace*, *agg*
                 2048          PS       0.25       8      **16**   **64**   512      32      **128**   
                 2153          CF       **8**      8      **16**   32       256      32      0.5       *agg*
  *E. faecium*   2102          CF       0.25       16     **16**   32       1024     32      **128**   
                 2141          PS       **8**      4      **16**   **64**   256      32      0.5       
  *E. hirae*     2062          CF       **16**     4      **8**    **64**   64       32      **128**   
                 2067          CF       **8**      4      **8**    **64**   256      64      **128**   
                 2068          CF       **16**     8      **8**    32       32       16      **16**    *ace*, *fsrA*
                 2071          PS       **16**     4      **8**    8        64       32      **128**   
                 2072          CF       0.25       4      **8**    **64**   64       64      **128**   
                 2089          CF       **8**      4      **8**    32       128      64      **128**   *atp*A

∗

Cut-off values \[proposed by the

EFSA-FEEDAP (2012)

\];

§

MICs are expressed in μg mL

\-

1

; n.r, not required; number in bold indicates antibiotic resistance. CF, cattle feces; PS, pens soil; FR, feed rations

.

Identification of Antibiotic Resistant Genes in Feedlot LAB Strains
-------------------------------------------------------------------

Given the high prevalence of CLI, ERY, GEN and TET resistances found for enterococci, only lactobacilli sensitive strains were subjected to PCR amplification for the detection of resistance genes. Antibiotic sensitive LAB strains in which resistance genes have been detected are shown in **Table [3](#T3){ref-type="table"}**. Seven of the 15 investigated genes were evidenced in feedlot lactobacilli. Although the presence of these genes were not always phenotypically correlated, molecular determinants for 27.5% of lactobacilli strains were found. While none of the feedlot strains was phenotypically resistant to AMP, PCR analysis showed *L. plantarum* CRL2103/CRL214 strains harboring *bla* genes. Similar results were reported for this lactobacilli species from swine and poultry meat, that even phenotypically negative, were found to carry *blaZ* gene ([@B7]). In contrast, although phenotypically resistant, [@B31] observed a lack of molecular detection of *bla* gene for *L. plantarum* starter strains. In addition, none of the feedlot lactobacilli was found to host GEN resistance gene, although *L. mucosae* CRL2158 was phenotypically resistant. Nevertheless, the presence of the *aac(6′)aph(2′′)* gene encoding for GEN resistance in lactobacilli isolated from chicken, pigs, pet and wild boars feces, was reported ([@B5]; [@B37]; [@B16]). Although phenotipically sensitive, the *aph(3′′)-III* gene conferring KAN resistance was present in *L. casei* CRL2088 in coincidence to that described for probiotic strain by [@B49]. Conversely, even when *L. plantarum* CRL2103 exhibited high phenotypic resistance (MIC ≥ 512 μg/ml), KAN resistance gene was absent. Likewise, from the genomic DNA of *L. mucosae* CRL2063/CRL2113 with a resistant phenotype to CHL, *cat* gene could not be amplified. Similarly, the occurrence of this gene was reported in *L. plantarum* CRL2126 with MIC ≥ 8 μg/ml (cut-off value) in coincidence with that reported for strains isolated from probiotic products ([@B59]). When STR resistance genes, *aadA* and *ant(6)* were evaluated, their presence in *L. casei* CRL2088 and *L. fermentum* CRL2085 strains were detected, MICs values were ≤ to cut-off value. The *aadA* gene was present in both lactobacilli strains, whereas *ant(6)* gene only occurred in the STR sensitive *L. fermentum* strain (MIC ≥ 4 μg/ml). Although phenotypic sensitivity to all assayed antibiotics, *L. fermentum* CRL2085 exhibited the co-occurrence of both STR resistance genes. Positive PCR for *aadA* gene in *L. casei* CRL2018 obtained in this study agrees with that reported for food and human strains, but none of the phenotypically resistant or sensitive food *L. fermentum* strains were positive for the investigated STR resistance genes ([@B49]). Resistance to aminoglycosides may result from various mechanisms, such as the lack of cytochrome electron transport responsible for antibiotic uptake, changes in cellular permeability and enzymatic antibiotic modification by acetyl-, adenyl-, and phospho-transferases, whose encoding genes are mostly found on plasmids and transposons ([@B3]).

Furthermore, a prevalence of *erm* and *tet* genes among feedlot lactobacilli was found (**Table [3](#T3){ref-type="table"}**). ERY resistance genes were identified as *ermB*, while TET resistance genes belonged to the *tet(S)* class. Six of 27 feedlot lactobacilli harbored *ermB* gene; *L. mucosae* CRL2101/CRL2113/CRL2114/CRL2154 phenotypically resistant to ERY (MICs ≥ 1 μg/ml) as well as *L. acidophilus* CRL2152 and *L. fermentum* CRL2085 susceptible to ERY (MICs ≤ 0.5 μg/ml) displayed positive PCR for *ermB* gene. In contrast to these results, *L. mucosae* strains from wild boars feces did not harbor ERY resistant genes ([@B37]). The detection of *ermB* as a major resistant gene for this class of antibiotic in bovine cattle LAB is consistent with that previously reported for lactobacilli from various sources ([@B5]; [@B31]; [@B36]; [@B6]; [@B46]). When TET resistance genes was analyzed, despite its high phenotypic prevalence with MICs far beyond the break point, a low occurrence of *tet*S gene was detected. This gene conferring resistance to TET was only present in the phenotypically resistant *L. plantarum* CRL2142, this being in coincidence with that found from food and human strains ([@B5]; [@B62]; [@B46]), whereas *L. mucosae* CRL2155 with a sensitive phenotype (MIC = 1 μg/ml), was PCR positive for *tetS* gene. Similarly, [@B37] reported sensitive *L. mucosae* isolates from wild boars as harboring *tetS* gene. Resistance *tet*S and *erm*B genes were identified on both, plasmids and the chromosome for *Lactobacillus* species from different fermented foods ([@B46]; [@B3]). The high level of resistance to ERY and TET in lactobacilli from feedlot environment is in agreement with the use of these antibiotics in veterinary therapy and for growth promotion in domestic and meat animals ([@B6]). Of the resistant lactobacilli and pediococci, eleven strains (28%) carried resistance genes, which was higher than that reported for LAB from dairy, pharmaceutical and probiotic products, in which only 12% of strains were PCR positive. From strains carrying resistance genes, only three correlated with phenotypic results (*L. plantarum* CRL2142 and *L. mucosae* CRL2101/2113 for TET and ERY, respectively). As recently reported by [@B30], the lack of correlation between phenotype and genotype may be explained by the intrinsic resistance to the tested antibiotics and the resistance emergence through evolutionary events such as mutations or defective expression of the resistance gene due to environmental and genetic modulation of the phenotypic expression of AR.

Identification of Virulence Factors
-----------------------------------

Enterococci and lactobacilli are commensal bacteria of the human and bovine GIT, but are also associated with clinical and community-acquired infections in humans ([@B23]). Genes encoding virulence factors were studied in feedlot LAB strains and results are shown in **Table [4](#T4){ref-type="table"}**. When enzymatic activities were examined, neither gelatinase nor β-hemolytic activities were exhibited by the analyzed LAB strains; all enterococci showed α-hemolysis, while lactobacilli (four *L. mucosae* strains) were also α-hemolytic, the remaining feedlot strains (85%) were γ-hemolytic or non-hemolytic (data not shown). In coincidence, none of the enterococci from pet animal's feces, food and water were β-hemolytic ([@B2]; [@B34]) although gelatinase activity was described for dairy and pet feces enterococci ([@B40]; [@B34]). In addition, the absence of β-hemolysis in feedlot enterococci that correlated with the lack of amplification of *cyl*A gene is in line with that reported for environmental enterococci ([@B50]). None of the feedlot lactobacilli harbored virulence factors genes (data not shown); these are generally regarded as safe due to their long history of presence in the normal GIT of humans and animals and safe use in fermented foods. However, lactobacilli have been associated with several cases of infections such as bacteremia, endocarditis but also with localized infections, *L. casei* and *L. rhamnosus* being common causative agents ([@B39]).

The frequency of genes encoding virulence factors among the feedlot enterococci strains is shown in **Table [4](#T4){ref-type="table"}**. Positive PCR amplification for accessory colonization factor (*ace*), aggregation substance (*agg*), quorum sensing (*fsrA*) and ATP synthase subunit alpha (*atpA*) genes were found for *E. durans* and *E. hirae* strains. In agreement with this result, the absence of genes coding for virulence factors in *E. faecium* from sheep feces was reported ([@B42]). In contrast, positive PCR for the other genes here evaluated was described for *E. faecium* from food, clinical and pet feces samples ([@B2]; [@B34]). The presence of *ace* gene was detected in feedlot *E. durans* and *E. hirae* strains, while *agg* gene was found in 2 out of 3 *E. durans* strains, *fsrA* and *atp*A genes being also PCR positive for *E. hirae* feedlot strains. On the contrary, a lack of amplification of the virulence genes here assayed was reported for *E. durans* and *E. hirae* from fermented sausages and pet feces ([@B45]; [@B22]; [@B34]). In particular, *fsrA* gene coding for quorum sensing regulatory mechanism was present in feedlot *E. hirae* CRL2068 in coincidence with that recently described for dairy strains by [@B51]. The lack of amplification of *fsrA* gene in *E. durans* feedlot strains agrees with that reported for this species by [@B25]. In addition, *atpA* gene encoding for the alpha subunit of ATP synthase was present in feedlot *E. hirae* CRL2089 in correlation with the use of this virulence determinant as identification probe for poultry *E. hirae* strains ([@B11]). Nevertheless, the absence of *gelE* gene in feedlot enterococci, in coincidence with the lack of gelatinase activity, agrees with that reported by [@B18] for *Enterococcus* species isolated from broilers chicken. Although the low incidence of virulence genes among feedlot enterococci, positive PCR genes were related to adhesion, colonization, biofilm formation and energy metabolism which may facilitate gene transfer in the GIT of meat animals and problematic pathogen lineages might arise.

Optimization of Growth Conditions for Selected Feedlot Probiotic LAB. Strains Compatibility
-------------------------------------------------------------------------------------------

Preliminary experiments to optimize the large-scale production required to deliver high numbers of probiotic live bacteria to feedlot cattle were performed; large-scale and low cost production of these bacteria is becoming an important issue. Therefore, the ability to produce a large number of cells, growth parameters and the use of low cost media ingredients should be considered for growth medium optimization. The selection of feedlot strains to be applied as probiotics previously carried out ([@B41]) together with safety traits (this study) allows the selection of *L. acidophilus* CRL2074, *L. amylovorus* CRL2116, *L. mucosae* CRL2069 and *L. rhamnosus* CRL2084 for a preliminary screening of optimal culture conditions to produce high cell mass. For this purpose, five different media involving several nitrogen (skim milk, soluble protein concentrate from whey, peptone casein, yeast extract) and carbon sources (glucose, lactose) were assayed, their composition being shown in **Table [2](#T2){ref-type="table"}**. Results showed a high dependence of lactobacilli growth on the composition of the different evaluated culture media (**Figure [1](#F1){ref-type="fig"}** and **Table [5](#T5){ref-type="table"}**). Different kinetics were displayed both measuring OD and CFU/mL counts. When OD~560~ max was determined in clear media (Mpep, Mgl, MRSc and MRS), *L. acidophilus*, *L. amylovorus* and *L. mucosae* were not able to grow in Mpep medium containing peptone, while *L. rhamnosus* exhibited a slight growth (**Figure [1](#F1){ref-type="fig"}**). A better growth was found for all four lactobacilli in Mgl medium (containing glucose) and higher OD~560~max were exhibited by *L. mucosae* and *L. rhamnosus* at 24 h. Nevertheless, maximal OD values were also observed for lactobacilli when MRSc was used; MRS (free pH) values were somewhat lower. When growth parameters were calculated from counts (CFU/mL) obtained by plate-dilution method, lactobacilli yielded the highest growth (\>10^9^ CFU/mL) when inoculated in Mgl, Mlac, MRS, and MRSc media; lower growth was obtained in Mw and Msm media while mostly poor growth was produced in Mpep medium. Highest cell numbers were reached in Mgl (*L. acidophilus* and *L. mucosae*), Mlac (*L. acidophilus*, *L. amylovorus*, and *L. rhamnosus*) and MRS (*L. acidophilus* and *L. mucosae*). As reported by [@B43], even when MRS medium represents a rich and suitable condition to support optimal lactobacilli growth, its high formulation cost and potential environmental hazards make it unviable for large-scale commercial applications. From our results, Mlac (g/l: skim milk, 10; yeast extract, 10; lactose, 30 pH: 6.5) and Mgl (g/l: yeast extract, 20; glucose, 10 pH: 5.9) showed the best conditions for the semi-industrial production of selected feedlot probiotic lactobacilli (**Table [5](#T5){ref-type="table"}**). The presence of sodium acetate in Mgl medium, a component of commercial MRS medium, was reported as energy source and selective agent for lactobacilli ([@B58]). On the other hand, whey protein concentrate (protein, 78%; carbohydrates, 4.5%) medium (Mw) as well as skim milk containing medium (Msm), a nitrogen (casein, ∼35%) and carbon (lactose, ∼50%) source respectively, were not able to produce high lactobacilli biomass. This result disagrees with economic and growth advantages of skim milk-based media used for LAB biomass production ([@B38]). In coincidence to that found by measuring OD (**Figure [1](#F1){ref-type="fig"}**), the lowest biomass production by the selected lactobacilli was obtained in peptone casein containing medium (Mpep), *L. acidophilus, L. amylovorus*, and *L. rhamnosus* displaying the lower CFU/mL max values (**Table [5](#T5){ref-type="table"}**). Particularly for *L. acidophilus*, [@B48] reported a growth decrease in the presence of peptone compared with skim milk in coincidence with results from this study. Modified media composed by yeast extract, glucose and sodium acetate/sodium glutamate as major ingredients omitting peptone (expensive nitrogen source) were used for biomass production by fecal *L. plantarum* strains intended to be used as probiotic ([@B32]). Optimized media containing agro-industrial residues such as cheese whey, industrial yeast extract, corn steep liquor, soybean meal and molasses among others, were assayed for lactobacilli biomass production ([@B32]; [@B13]; [@B43]). In view to be used as probiotic mixture, a final *Lactobacillus* strains compatibility was carried out. Results indicated that there was not inhibition of one strain on the growth of another.

![Growth kinetics of probiotic lactobacilli strains in different culture media. **(A)** *Lactobacillus acidophilus* CRL 2074, **(B)** *L. amylovorus* CRL 2116, **(C)** *L. mucosae* CRL 2069, and **(D)** *L. rhamnosus* CRL 2084.](fmicb-09-02220-g001){#F1}

###### 

Growth parameters of selected probiotic lactobacilli strains.

  Strains                    Growth parameters   Culture media                                                                              
  -------------------------- ------------------- --------------- -------------- -------------- -------------- -------------- -------------- --------------
                             μ (h^-1^)           0.06            0.76           0.67           0.10           0.13           0.48           0.31
  *L. acidophilus* CRL2074   Growth potential    0.07            4.97           4.40           0.22           0.30           2.12           1.35
                             CFU/ml max          1.20 × 10^3^    2.80 × 10^9^   2.80 × 10^9^   2.00 × 10^5^   1.00 × 10^5^   1.08 × 10^9^   1.20 × 10^8^
                             OD~560~ ~nm~ max    0.30            1.70           ND             ND             ND             1.50           1.80
                             μ (h^-1^)           0.05            0.22           0.39           0.15           0.18           0.45           0.84
  *L. amylovorus* CRL2116    Growth potential    0.11            3.13           4.11           1.60           2.14           1.97           3.67
                             CFU/ml max          1.30 × 10^4^    9.55 × 10^7^   1.29 × 10^9^   4.00 × 10^6^   1.40 × 10^7^   5.14 × 10^8^   9.70 × 10^8^
                             OD~560~ ~nm~ max    0.10            1.30           ND             ND             ND             1.80           1.90
                             μ (h^-1)^           0.08            1.10           0.36           0.78           0.10           0.51           0.44
  *L. mucosae* CRL2069       Growth potential    0.18            4.78           2.39           5.14           1.00           1.29           0.96
                             CFU/ml max          1.70 × 10^5^    6.03 × 10^9^   8.90 × 10^8^   1.40 × 10^8^   1.00 × 10^6^   1.62 × 10^9^   1.23 × 10^8^
                             OD~560~ ~nm~ max    0.15            1.80           ND             ND             ND             1.60           1.8
                             μ (h^-1^)           0.20            0.58           0.56           0.42           0.36           0.62           0.38
  *L. rhamnosus* CRL2084     Growth potential    2.08            0.75           2.44           1.86           1.57           1.11           1.69
                             CFU/ml max          2.48 × 10^7^    3.24 × 10^8^   1.12 × 10^9^   1.80 × 10^8^   2.00 × 10^8^   7.55 × 10^8^   8.70 × 10^8^
                             OD~560~ ~nm~ max    0.60            1.85           ND             ND             ND             1.70           1.90

ND, no determined;

†

MRSc, MRS pH controlled; OD

560

nm

max was determined only in clear media at the incubation time indicated in brackets

.

Conclusion
==========

From this study, LAB isolated from steers feces, soil pens and feed rations were found as a reservoir of AR and virulence genes. However, *L. acidophilus* CRL2074, *L. amylovorus* CRL2116, *L. mucosae* CRL2069 and *L. rhamnosus* CRL2084 were able to be selected as probiotic candidates being free of AR and virulence factors, reaching high cell numbers in optimal culture media and compatible among them. These strains, alone or in combination, are being administered to feedlot steers for *in vivo* studies to elucidate their health and productivity benefits.
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